Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
about
Stem/Progenitor Cell Niches Involved in Hepatic and Biliary RegenerationAlpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitroA Transcriptomic Signature of Mouse Liver Progenitor CellsThe hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: A new reference frame for disease and regeneration.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Hyaluronan coating improves liver engraftment of transplanted human biliary tree stem/progenitor cells.Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Emerging Opportunities for Target Discovery in Rare Cancers.Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.Environmental exposures as a risk factor for fibrolamellar carcinoma.Stem/progenitor cells and reprogramming (plasticity) mechanisms in liver, biliary tree, and pancreas.The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
P2860
Q26765898-6F57C5CB-2B89-4FCA-818A-82AD1954FFBFQ36965059-62007388-F1DD-49BC-8675-8CDB27B7D7FCQ37335215-6B2D5720-5CF2-4257-95B5-5E968B391F92Q38622477-2A89823B-A603-484B-A5AB-67F72DF4CD25Q38720813-E345FA1D-31C8-4947-B1A2-1686AF444091Q38724218-A77722F6-BAAD-4B35-8E3A-79C7A3E686FAQ38901483-D8A83728-8C6B-43AA-BB5F-34EE00E55B90Q41670848-EF1720CA-A19B-4C89-B83B-52463533161BQ42314952-55921781-5147-4A5D-B329-2C56D9FC6639Q46447893-A4F87C84-9F59-4207-8FB9-1D550F0ABE14Q47377422-ED0620CC-D2FD-4EE8-B977-EEF5C5FE93F1Q47635386-D187F9EB-9447-4BE9-970C-26143E8EB03CQ47941750-524E02CC-BCD1-4387-8C89-AF14426296FFQ48317424-568A2A5E-30D6-49C1-9D38-02744BE76226Q51751398-927C5A56-7906-40E4-B548-B5C17C682C69Q52657106-94FA611D-DD19-4538-B653-041E902A509BQ52689575-B7E06413-DAC3-4A43-BA1E-A19DE528A865Q52897650-B1C40C61-06F6-4B78-B26C-9ED39A7DE1B6Q53117432-02E3510C-FCE3-4517-B4BA-202ABA60EC09Q54237690-E4731D60-89A5-4321-AF46-CBAA03560FC6
P2860
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@ast
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@en
type
label
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@ast
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@en
prefLabel
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@ast
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@en
P2093
P2860
P50
P356
P1476
Model of fibrolamellar hepatoc ...... nrichment in cancer stem cells
@en
P2093
Andrea Reyna-Neyra
David Klimstra
Eliane Wauthier
Eugenio Gaudio
Lola M Reid
Nancy Carrasco
Praveen Sethupathy
Ronald Levine
Sara R Selitsky
Timothy A Dinh
P2860
P2888
P356
10.1038/NCOMMS9070
P407
P577
2015-10-06T00:00:00Z